EGEGazette
Live
Houthis Accuse Saudi Arabia of 28 Airstrikes in 24 Hours; U.S. Intelligence Chief Visits CairoWashington Warns Citizens of Unexpected Escalation in Middle EastIran Says Strait of Hormuz Will Stay Closed Until US Meets Its ConditionsTrump faces dual setback as U.S. courts block voting and immigration restrictionsLawsuit Filed Against Trump and His Company Over Paid Early Access Service to His PostsTrump Renews Bid to Restrict Birthright Citizenship Through Curbing "Birth Tourism"Trump Cuts Camp David Vacation Short Amid Middle East Escalation WarningsTrump Cuts Short Vacation, Returns to White House as US Issues "Possible Escalation" Warning in Middle EastReporters From CNN, MS NOW and Politico Denied White House Access After Trump BanFederal Immigration Agent Shoots and Injures Man in Austin, TexasPowerful Explosions Reported in Syria's Aleppo CountrysideSix Pakistani soldiers, including two officers, killed in clash near Afghan border
healthReported

Blood Test Shows Early Promise for Detecting Pancreatic Cancer, Report Says

A new blood-based test aims to identify pancreatic cancer before it reaches advanced stages, according to a report by Scientific American.

· 1 min read · language: en
Article image
Scientific American

A blood test under development is showing early promise in detecting pancreatic cancer before it progresses to advanced stages, according to a report published by Scientific American.

Pancreatic cancer is typically diagnosed at its latest stages, when treatment options are limited and outcomes are poor, the report noted. Researchers have long sought a reliable method to catch the disease earlier, when it is more treatable, a goal some in the field have described as a "holy grail" for pancreatic cancer research, according to the report.

The report did not provide extensive detail on the specific mechanism, developers, or clinical trial data behind the test, but framed the development as a significant step toward earlier detection of a cancer known for its difficulty to diagnose in time.

Scientific American's report emphasized the broader challenge in pancreatic cancer care: the disease often produces few symptoms until it has spread, making early screening tools especially valuable if validated through further research.

Further details on the test's accuracy, the research team involved, and the timeline for potential clinical use were not specified in the available excerpt of the report.

Sources

EGazette summarizes reporting from multiple sources; follow the links for the originals.

Also available in: ARFRTR

Related articles

Comments

Sign in to join the conversation.

Forgot password?

No account?

Loading comments…